For rapid whole blood testing, Hemochron Signature Elite system standardizes ACT+, ACT-LR, PT and APTT testing at the point of care. Rapid, accurate and reproducible results, for patient management decisions in acute care settings, from the Cardiovascular Operating Room to the Cardiac Catherization Lab.
Rapid Whole Blood Hemostasis testing in acute care settings.
Broadest test menu for rapid point-of-care Hemostasis diagnosis and monitoring
Hemochron Signature Elite system offers the broadest menu for rapid whole blood Hemostasis diagnosis and monitoring including both high and low heparin ranges (ACT+, ACT-LR) as well as PT and APTT. Ideal across a range of point-of-care settings: Cardiovascular Operating Room, Cardiac Catheterization Lab, Interventional Neuroradiology Suite, Emergency Department, Intensive Care Unit, Anticoagulation Clinic.
- Broadest test menuACT+ accurately measures heparin effects (1.0-6.0 u/mL blood); ACT-LR, sensitive to low heparin doses (0.0-2.5 u/mL blood), is the only low-range POC assay indicated for use during Extracorporeal Life Support (ECLS), Percutaneous Coronary Intervention (PCI), vascular procedures, neurointerventional procedures, dialysis. PT/Citrate PT report INR with an effective INR range of 0.8-10.0 as well as whole blood seconds and plasma equivalent seconds. Our APTT and Citrate APTT report whole blood seconds and plasma equivalent seconds on samples containing heparin levels up to 1.5 U/mL. Complete Assay Menu: ACT+, ACT-LR, PT, Citrate PT, APTT, Citrate APTT
- Fast and simpleFast, accurate reproducible results for critical patient-management decisions. Simple, single-use, cartridge-based technology measures fibrin clot formation.
- Connectivity and complianceTo maximize efficiency and ensure regulatory compliance, automatic internal electronic Quality Control (QC) with QC lockout, including cartridge and QC expiration, as well as operator tracking and lockout. Direct connection to Ethernet and major information systems. POCT-1A compliant.